Korea South
Monolabs is a pioneering healthcare platform company established in 2018 with a mission to alleviate the financial burden and societal challenges associated with an aging population. Distinguished as the sole enterprise to proficiently introduce personalized nutrition subscriptions, on-site healthcare services, telemedicine provisions, and pharmaceutical distribution networks, Monolabs has achieved a comprehensive healthcare ecosystem that sets it apart.
The company, headquartered in South Korea, operates within the Digital Media, Health Care, and Information Technology industries. Its slogan, "Personalized Supplements, AI, Blockchain, SCM" reflects its innovative approach towards enhancing global health through technology.
Monolabs recently secured a significant KRW12.50B Series B investment on 01 July 2022 from a consortium of investors including CTK Investments, MainStreet Investment Management, and Cheongbo Industrial Co. (CBI). This substantial investment underscores the confidence of industry players in the company's vision and potential for future growth and impact on the healthcare sector.
